Followers | 22 |
Posts | 1797 |
Boards Moderated | 0 |
Alias Born | 11/22/2015 |
Thursday, February 15, 2018 11:19:42 AM
It's not an overnight thing but the chart is recovering like a champ right now....gotta be a reason for it. I think the news was a BIG milestone for them. Probably one of the best things they could have announced. The FDA process takes time but look at any company that:
1. Went through FDA trials and;
2. Was Approved/Cleared for their product/technology/therapy
When that happened to those companies it had everyone on the sidelines saying "Man I wish I was in that stock before all that happened."
I'm not saying anything is a definite because it can work in the opposite direction too but that's why it's speculative right now..I just hope it ends up in our favor after these trials. For now we've got a stock under $0.40 that previously tested levels near $0.50 that is night and day different from where it was just a few months ago and there's still time to have this on watch before any other developments come about.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM